Skip to content

Author

Dinesh Kumar

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Aug 2026

Bioplastic Nanoparticles as Next‐Generation Sustainable Materials: Design Principles, Technological Advances, and Translational Applications

Persistent petroleum‐derived plastics have presented environmental problems, and this has amplified the world's interest in biodegradable and renewable alternatives. Bioplastic nanoparticles, as a novel class of materials with sustainability and improved performance, are among them. This review presents the main categories of bioplastics derived from natural, microbial, and chemically modified sources, highlighting their structural features and physicochemical properties. Special attention is paid to the role of nanotechnology in overcoming the drawbacks generally associated with traditional bioplastics, such as low mechanical strength, inadequate thermal stability, and barrier performance. Different fabrication strategies such as top‐down, bottom‐up, and green synthesis approaches and their impact on size, morphology, and functionality of nanoparticles are discussed. Moreover, the review also includes surface engineering and functionalization techniques that provide better stability, targeting, and response to external stimuli. The study discusses the degradability of bioplastics in composting, soil, and aqueous environment along with the processes involved in making bioplastics useful for lab and industrial scale manufacture. Moreover, the review also considers the fate of residual bioplastics under environmental conditions in which bioplastics may not completely degrade, pointing out the possible risks from ecotoxicology and drawbacks of biodegradable claims under natural environmental conditions. Specific focus is placed on issues related to the translation of technology into clinical and industrial setting. In addition, the increasing applications of bioplastic nanoparticles in drug delivery, gene therapy, vaccine systems, food packaging, agriculture, and environmental remediation are reviewed critically. While significant progress has been achieved, scalability, economic feasibility, safety assessment, and regulatory compliance still pose challenges to large‐scale implementation. Emerging developments in synthetic biology, artificial intelligence‐assisted formulation design, and evolving regulatory frameworks are discussed as key factors expected to influence the future advancement and commercialization of nanoengineered bioplastic systems. This review summarizes the paradigm shifting impact of nanoengineered bioplastics on sustainable material science and discusses future prospects for their safe and effective implementation in a variety of industrial sectors.

Ayushi Jain, Charan Singh, Dinesh Kumar et al. · 0 citations
Review Open access Jul 2026

Dual‐Drug‐Loaded Liposomes: Design Strategies, Mechanistic Insights, and Therapeutic Applications in Cancer

Liposomal nanocarriers are clinically established platforms for targeted drug delivery due to their biocompatibility and ability to encapsulate both hydrophilic and hydrophobic agents. However, conventional single‐drug liposomes are limited by suboptimal efficacy, systemic toxicity, and multidrug resistance. Dual‐drug‐loaded liposomes (DDLs) address these limitations by enabling co‐delivery of synergistic agents within a single nanocarrier. This review provides an integrated analysis of DDL systems, focusing on formulation design, drug loading strategies, and key physicochemical parameters governing encapsulation efficiency and controlled release. Mechanistic insights into therapeutic enhancement are highlighted, including modulation of efflux transporters, reversal of epithelial–mesenchymal transition, and synchronized intracellular delivery. The impact of ligand‐mediated functionalization on tumor targeting and cellular uptake is also critically evaluated. Unlike existing reviews, this work provides a unified framework integrating formulation design, mechanistic insights into drug synergy, and translational challenges specific to DDLs, addressing a critical gap in the existing literature. Preclinical and clinical evidence, including approved formulations such as Vyxeos, is discussed. Remaining barriers include scale‐up, reproducibility, immune interactions, and regulatory complexity. Future directions emphasize personalized and stimulus‐responsive nanomedicine for improved cancer therapy.

Neelam Sinha, Rohan Chand Sahu, Rohit Patil et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.